Webster James C.
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Webster James C.. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| INVX | VP, Gen Counsel & Secretary | Tax Withholding | 25,238 | $15.41 | $388,918 | Sep 6, 2024 |
| INVX | VP, Gen Counsel & Secretary | Sale | 6,000 | $14.67 | $88,020 | Aug 12, 2024 |
| INVX | VP, Gen Counsel & Secretary | Sale | 4,000 | $23.16 | $92,640 | Apr 1, 2024 |
| INVX | VP, Gen Counsel & Secretary | Sale | 4,000 | $23.14 | $92,560 | Jan 2, 2024 |
| INVX | VP - Gen Counsel & Secretary | Tax Withholding | 8,009 | $22.78 | $182,445 | Oct 28, 2023 |
| INVX | VP - Gen Counsel & Secretary | Sale | 2,000 | $29.98 | $59,960 | Apr 3, 2023 |
| INVX | VP - Gen Counsel & Secretary | Sale | 189 | $27.06 | $5,114 | Jan 3, 2023 |
| INVX | VP - Gen Counsel & Secretary | Award / Grant | 21,477 | — | — | Oct 31, 2022 |
| INVX | VP - Gen Counsel & Secretary | Sale | 2,000 | $20.75 | $41,500 | Oct 3, 2022 |
| INVX | VP - Gen Counsel & Secretary | Sale | 3,046 | $25.93 | $78,983 | Jul 1, 2022 |
| INVX | VP - Gen Counsel & Secretary | Sale | 4,087 | $36.83 | $150,524 | Apr 1, 2022 |
| INVX | VP - Gen Counsel & Secretary | Sale | 653 | $20.41 | $13,328 | Jan 3, 2022 |
| INVX | VP - Gen Counsel & Secretary | Award / Grant | 10,443 | — | — | Oct 28, 2021 |
| INVX | VP - Gen Counsel & Secretary | Sale | 3,349 | $25.81 | $86,438 | Oct 1, 2021 |
| INVX | VP - Gen Counsel & Secretary | Sale | 5,000 | $34.55 | $172,750 | Jul 1, 2021 |
| INVX | VP - Gen Counsel & Secretary | Sale | 10,000 | $32.96 | $329,600 | Apr 1, 2021 |
| INVX | VP - Gen Counsel & Secretary | Sale | 12,437 | $23.60 | $293,513 | Oct 28, 2020 |
| INVX | VP - Gen Counsel & Secretary | Sale | 10,000 | $24.03 | $240,300 | Oct 1, 2020 |
| INVX | VP - Gen Counsel & Secretary | Sale | 1,392 | $44.73 | $62,264 | Nov 7, 2019 |
| INVX | VP - Gen Counsel & Secretary | Award / Grant | 17,336 | — | — | Oct 29, 2019 |
| INVX | VP - Gen Counsel & Secretary | Sale | 2,077 | $49.30 | $102,396 | Oct 1, 2019 |
| INVX | VP - Gen Counsel & Secretary | Sale | 2,000 | $45.84 | $91,680 | Apr 1, 2019 |
| INVX | VP - Gen Counsel & Secretary | Sale | 2,581 | $41.86 | $108,041 | Oct 29, 2018 |
| INVX | VP - Gen Counsel & Secretary | Sale | 2,000 | $52.35 | $104,700 | Oct 1, 2018 |
| INVX | VP - Gen Counsel & Secretary | Sale | 1,830 | $43.95 | $80,429 | Apr 2, 2018 |
| INVX | VP - Gen Counsel & Secretary | Award / Grant | 10,843 | — | — | Oct 28, 2017 |
| INVX | VP - Gen Counsel & Secretary | Sale | 2,000 | $43.49 | $86,980 | Oct 2, 2017 |
| INVX | VP - Gen Counsel & Secretary | Sale | 5,888 | $52.93 | $311,652 | Nov 16, 2016 |
| INVX | VP - Gen Counsel & Secretary | Sale | 3,094 | $47.59 | $147,243 | Oct 28, 2016 |
| INVX | VP - Gen Counsel & Secretary | Award / Grant | 6,390 | — | — | Oct 29, 2015 |
| INVX | VP - Gen Counsel & Secretary | Award / Grant | 5,683 | — | — | Oct 27, 2015 |
| INVX | VP - Gen Counsel & Secretary | Sale | 755 | $76.56 | $57,803 | Dec 9, 2014 |
| INVX | VP - Gen Counsel & Secretary | Sale | 436 | $91.77 | $40,012 | Oct 29, 2014 |
| INVX | VP - Gen Counsel & Secretary | Sale | 693 | $87.99 | $60,977 | Oct 28, 2014 |
| INVX | VP-General Counsel & Secretary | Award / Grant | 4,614 | — | — | Oct 28, 2014 |
| INVX | VP - Gen Counsel & Secretary | Sale | 774 | $108.93 | $84,312 | Dec 9, 2013 |
| INVX | VP - Gen Counsel & Secretary | Sale | 660 | $116.37 | $76,804 | Oct 28, 2013 |
| INVX | VP-General Counsel & Secretary | Award / Grant | 3,423 | — | — | Oct 28, 2013 |
| INVX | VP - General Counsel and Sec | Sale | 753 | $70.35 | $52,974 | Dec 10, 2012 |
| INVX | VP-General Counsel & Secretary | Award / Grant | 5,250 | — | — | Oct 26, 2012 |
| INVX | VP - General Counsel and Sec. | Award / Grant | 6,000 | — | — | Dec 8, 2011 |